SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Page 5 of 37
Newsletters
‘None of these scenarios is good for the business.’ Inside Ikea’s decision to withdraw from Russia
By
Bernhard Warner
and
Alan Murray
April 6, 2022
Newsletters
The 5 forces that will transform business over the next decade
By
Bernhard Warner
and
Alan Murray
April 4, 2022
Newsletters
Is it time to rethink CEO pay for companies receiving billions in state aid and subsidies?
By
Bernhard Warner
and
Alan Murray
April 1, 2022
Success
How Moderna kept its mostly millennial staff from burning out while developing the COVID vaccine
By
Jane Thier
March 31, 2022
Health
Omicron has all but wiped out the more deadly Delta strain—but that’s not necessarily a good thing
By
Christiaan Hetzner
March 31, 2022
Newsletters
Business leaders challenge fellow CEOs to raise their game on net-zero commitments
By
Bernhard Warner
and
Alan Murray
March 31, 2022
Health
FDA approves additional Pfizer and Moderna COVID boosters for adults 50 and older
By
Lauran Neergaard
,
Matthew Perrone
and
The Associated Press
March 29, 2022
Newsletters
The pandemic has accelerated innovation across industries—particularly in health care
By
Bernhard Warner
and
Alan Murray
March 28, 2022
Health
Pfizer shares slide after it recalls blood pressure drug over cancer-risk fears
By
Sophie Mellor
March 23, 2022
Health
The weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
By
Andrew Marquardt
March 15, 2022
Health
China just locked down 50 million people amid ‘stealth Omicron’ fears. The former FDA head predicts what happens next
By
Marco Quiroz-Gutierrez
March 15, 2022
International
Pfizer pauses clinical trials in Russia, says it will continue to send drugs to patients
By
Riley Griffin
and
Bloomberg
March 14, 2022
Health
Pfizer CEO says new COVID variants might make four—or more—vaccine doses ‘necessary’ for returning to normal
By
Nicholas Gordon
March 14, 2022
Newsletters
Pfizer CEO on cracking COVID: ‘Companies that stay true to their purpose perform far better’
By
Bernhard Warner
and
Alan Murray
March 8, 2022
Health
Scientists have discovered 16 new genetic markers that predispose you to severe illness from COVID
By
Andrew Marquardt
March 7, 2022
Most Popular
Success
Billionaire who sold two companies to Coca-Cola says he tries to convince people not to become entrepreneurs: 'Every...
By
Dave Smith
Success
Meet a 23-year-old electrician who was a 'good student' but skipped college to join Gen Z's blue-collar revolution. He...
By
Nick Lichtenberg
AI
Ray Dalio calls for wealth 'redistribution policy' when AI and humanoid robots start to benefit the 1% to 10% more than...
By
Nick Lichtenberg